Esperion Therapeutics, Inc. (LON:0IIM)
0.7862
-0.1139 (-12.65%)
At close: May 9, 2025
Esperion Therapeutics Employees
Esperion Therapeutics had 304 employees as of December 31, 2024. The number of employees increased by 64 or 26.67% compared to the previous year.
Employees
304
Change (1Y)
64
Growth (1Y)
26.67%
Revenue / Employee
660.88K GBP
Profits / Employee
-390.11K GBP
Market Cap
118.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Esperion Therapeutics News
- 5 days ago - CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - Benzinga
- 6 days ago - Earnings Scheduled For May 6, 2025 - Benzinga
- 6 days ago - Esperion Therapeutics Q1 2025 Earnings Preview - Seeking Alpha
- 16 days ago - Esperion to Participate in The Citizens Life Sciences Conference - GlobeNewsWire
- 17 days ago - Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025 - GlobeNewsWire
- 18 days ago - Esperion to Report First Quarter 2025 Financial Results on May 6 - Benzinga
- 4 weeks ago - Esperion to Host R&D Day to Highlight Cardiometabolic Pipeline Innovation and Next-Generation Therapeutics on April 24, 2025 - GlobeNewsWire
- 5 weeks ago - Esperion Appoints Robert E. Hoffman to Board of Directors - GlobeNewsWire